Trends in Prevalence Cases and Disability-Adjusted Life-Years of Parkinson’s Disease: Findings from the Global Burden of Disease Study 2019

医学 疾病 帕金森病 人口学 社会经济地位 疾病负担 疾病负担 流行 老年学 公共卫生 环境卫生 人口 内科学 病理 社会学
作者
Qiongqiong Zhong,Feng Zhu
出处
期刊:Neuroepidemiology [S. Karger AG]
卷期号:56 (4): 261-270 被引量:21
标识
DOI:10.1159/000524208
摘要

<b><i>Background:</i></b> Parkinson’s disease is a common, age-related progressive neurodegenerative disorder with considerable socioeconomic burdens, although the studies in incremental burdens to the disease’s rapid growth are incomplete and lag behind. We aim to assess global burdens of Parkinson’s disease based on a public database online. <b><i>Methods:</i></b> Based on the Global Burden of Disease, Injuries, and Risk Factors Study, we screened a range of indicators including prevalence cases, disability-adjusted life-years (DALYs), age-standardized prevalence rates (ASPRs), and age-standardized DALY rate (ASDR). The join point regression was used to assess the indicators, wherein the ASPR and the ASDR were referred to temporal trends for burdens of Parkinson’s disease. <b><i>Results:</i></b> Prevalence cases of global Parkinson’s disease were on the rise for 30 years, with an increase of 155.51% during 1990–2019. Temporal trend of ASDRs was on the rise during 1990–2002 but in decline during 2002–2019. The ASPRs had a turning point in 2017 and a decline during 2017–2019 (annual percentage change = −0.51%, <i>p</i> &#x3e; 0.05). China, India, the USA, Japan, and Germany shared the five highest prevalence cases and DALYs in 2019. The Socio-Demographic Index (SDI) was in relation to a significantly positive ASPR (<i>R</i> = 0.61, <i>p</i> &#x3c; 0.001) but not a significantly negative ASDR (<i>R</i> = −0.044, <i>p</i> = 0.53), respectively. <b><i>Conclusions:</i></b> In this study, a range of indicators for global burdens of Parkinson’s disease were on the rise during 1990–2019. Tremendous efforts should be in place to prevent Parkinson’s disease, especially among the populations of males, with advanced ages, in East Asia, and in regions with high SDI.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
方圆完成签到,获得积分10
1秒前
1秒前
玲珑油豆腐完成签到,获得积分10
1秒前
1秒前
2秒前
星辰大海应助秋辞采纳,获得10
2秒前
2秒前
科研通AI5应助OceanBlvdforme采纳,获得10
2秒前
VDC发布了新的文献求助10
2秒前
3秒前
香蕉觅云应助DXXX采纳,获得10
4秒前
4秒前
海鸥海鸥发布了新的文献求助30
4秒前
4秒前
深情安青应助系统提示采纳,获得10
4秒前
传奇3应助阿宝采纳,获得10
5秒前
韭黄发布了新的文献求助10
5秒前
6秒前
桐桐应助玲珑油豆腐采纳,获得10
6秒前
charih完成签到 ,获得积分10
6秒前
hxy808关注了科研通微信公众号
7秒前
佚小满完成签到,获得积分10
7秒前
c123完成签到 ,获得积分10
8秒前
8秒前
berry发布了新的文献求助10
8秒前
超11发布了新的文献求助10
8秒前
9秒前
9秒前
隐形曼青应助烩面大师采纳,获得10
9秒前
9秒前
默然的歌完成签到 ,获得积分10
9秒前
CTL发布了新的文献求助10
10秒前
10秒前
10秒前
大鹏完成签到,获得积分10
10秒前
10秒前
10秒前
congguitar发布了新的文献求助10
11秒前
CodeCraft应助韭黄采纳,获得10
11秒前
11秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527699
求助须知:如何正确求助?哪些是违规求助? 3107752
关于积分的说明 9286499
捐赠科研通 2805513
什么是DOI,文献DOI怎么找? 1539954
邀请新用户注册赠送积分活动 716878
科研通“疑难数据库(出版商)”最低求助积分说明 709759